Concepedia

Maria Wolodarski

MW

Statistics

Publications

7

Citations

403

H-Index

7

Active since

2016

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Heidelberg University

Fondazione IRCCS Istituto Nazionale dei Tumori

German Cancer Research Center

Maria Wolodarski is an author at Karolinska Institutet specializing in oncology, melanoma immunotherapy, and cancer immunotherapy.

Publications per year

2016–2023

7

Publications

7

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Yago Pico de Coaña, Maria Wolodarski, Isabel Poschke et al. · Oncotarget · 2017 · 142 citations · Full text

, , +17

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

Rossana Tallerico, Costanza Maria Cristiani, Elina Staaf et al. · OncoImmunology · 2016 · 65 citations · Full text

, , +17

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in <i>NRAS</i>-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

Filippo de Braud, Christophe Dooms, Rebecca S. Heist et al. · Journal of Clinical Oncology · 2023 · 51 citations · Full text

, , +12

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

Tanja Lövgren, Maria Wolodarski, Stina L. Wickström et al. · OncoImmunology · 2020 · 50 citations · Full text

, , +17

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Yago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila et al. · OncoImmunology · 2020 · 47 citations · Full text

, , +17

1–5 of 7